Tomoyuki Goto

Correction: Good local control acquired by chemoradiation for inoperable adenocarcinoma of the anal canal with pagetoid spread: a report of two cases.

Journal: International cancer conference journal

Published: July 23, 2026

A blended learning program sustains pharmacists' oral health support competency for 15 months: A longitudinal study.

Journal: Drug discoveries & therapeutics

Published: February 11, 2026

Atezolizumab plus Bevacizumab versus Lenvatinib as First-Line Treatment for Unresectable Hepatocellular Carcinoma Stratified by the CRAFITY Score: An International Multicenter Study.

Journal: Liver cancer

Published: February 06, 2026

Impact of changes in cardiopulmonary bypass circuit design on pressure loss, wall shear stress, and venous drainage flow.

Journal: Perfusion

Published: October 09, 2025

A Unique Body Floss Technique for Reduction of Sealing Loss on the Lesser-Curvature Side in Thoracic Endovascular Repair.

Journal: Annals of thoracic surgery short reports

Published: August 05, 2025

Anterolateral Partial Sternotomy as an Effective Approach for Open Repair After Debranching Thoracic Endovascular Aortic Repair in Aortic Arch Aneurysm

Journal: Kyobu geka. The Japanese journal of thoracic surgery

Published: July 17, 2025

Lenvatinib Versus Atezolizumab Plus Bevacizumab as First-Line Treatment for Advanced Hepatocellular Carcinoma With a CRAFITY Score of 2: A Multi-Center Retrospective Study.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: June 20, 2025

Good local control acquired by chemoradiation for inoperable adenocarcinoma of the anal canal with pagetoid spread: a report of two cases.

Journal: International cancer conference journal

Published: June 19, 2025

Publisher Correction: CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study.

Journal: Journal of gastroenterology

Published: October 21, 2024

Vanishing Left Atrial Mass in a Middle-aged Woman: Spontaneous Intramural Left Atrial Hematoma in Isolated Atrial Amyloidosis.

Journal: Circulation. Cardiovascular imaging

Published: July 31, 2024

CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study.

Correction: Good local control acquired by chemoradiation for inoperable adenocarcinoma of the anal canal with pagetoid spread: a report of two cases.

Correction: Good local control acquired by chemoradiation for inoperable adenocarcinoma of the anal canal with pagetoid spread: a report of two cases.

A blended learning program sustains pharmacists' oral health support competency for 15 months: A longitudinal study.

A blended learning program sustains pharmacists' oral health support competency for 15 months: A longitudinal study.

Atezolizumab plus Bevacizumab versus Lenvatinib as First-Line Treatment for Unresectable Hepatocellular Carcinoma Stratified by the CRAFITY Score: An International Multicenter Study.

Atezolizumab plus Bevacizumab versus Lenvatinib as First-Line Treatment for Unresectable Hepatocellular Carcinoma Stratified by the CRAFITY Score: An International Multicenter Study.

Impact of changes in cardiopulmonary bypass circuit design on pressure loss, wall shear stress, and venous drainage flow.

Impact of changes in cardiopulmonary bypass circuit design on pressure loss, wall shear stress, and venous drainage flow.

A Unique Body Floss Technique for Reduction of Sealing Loss on the Lesser-Curvature Side in Thoracic Endovascular Repair.

A Unique Body Floss Technique for Reduction of Sealing Loss on the Lesser-Curvature Side in Thoracic Endovascular Repair.

Anterolateral Partial Sternotomy as an Effective Approach for Open Repair After Debranching Thoracic Endovascular Aortic Repair in Aortic Arch Aneurysm

Anterolateral Partial Sternotomy as an Effective Approach for Open Repair After Debranching Thoracic Endovascular Aortic Repair in Aortic Arch Aneurysm

Lenvatinib Versus Atezolizumab Plus Bevacizumab as First-Line Treatment for Advanced Hepatocellular Carcinoma With a CRAFITY Score of 2: A Multi-Center Retrospective Study.

Lenvatinib Versus Atezolizumab Plus Bevacizumab as First-Line Treatment for Advanced Hepatocellular Carcinoma With a CRAFITY Score of 2: A Multi-Center Retrospective Study.

Good local control acquired by chemoradiation for inoperable adenocarcinoma of the anal canal with pagetoid spread: a report of two cases.

Good local control acquired by chemoradiation for inoperable adenocarcinoma of the anal canal with pagetoid spread: a report of two cases.

Publisher Correction: CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study.

Publisher Correction: CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study.

Vanishing Left Atrial Mass in a Middle-aged Woman: Spontaneous Intramural Left Atrial Hematoma in Isolated Atrial Amyloidosis.

Vanishing Left Atrial Mass in a Middle-aged Woman: Spontaneous Intramural Left Atrial Hematoma in Isolated Atrial Amyloidosis.

CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study.

CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study.

Efficacy of pazopanib in FGFR1-amplified uterine carcinosarcoma: A case report.

Efficacy of pazopanib in FGFR1-amplified uterine carcinosarcoma: A case report.